Australia's largest stock trading and investment forum Australia's #1 stock forum

Short Term Trading Week Starting: 30 Aug, page-63

First 63 Last

Share
Profile

Follow
zenvestor

1,937 Posts.

14

03/09/21

19:18

Post #: 55822439
Share

Originally posted by rastus1: ↑

ATH:

"Our opportunity is big, and we are motivated by our purpose to give people living with debilitating
neurodegenerative diseases an alternate future. A future where our therapies change the course of their
disease, treat their symptoms, and significantly improve both quality and duration of life. We are seeing
the convergence of several big themes. Treatments for the underlying causes of the ageing mind like
Alzheimer’s disease have eluded scientists, clinicians, and big pharma. However, we are starting to see
progress and recent drug approvals that give hope to the large populations around the world who will
develop these diseases in the future. True also for other neurodegenerative diseases, such as
Parkinsonian disorders on which we are focused, that have no cure, few treatments of symptoms, and are
debilitating. The need for treatments that can alter the future for these patients has never been greater
and this remains an important ambition for Alterity."

refer to todays AR for more info.

Expand

addresses neurodegenerative disease so great future for post vaccination period.
Upvote

0 Great analysis

Reply

There are more pages in this discussion • 1 more message in this thread...

First 63 Last

SPONSORED BY